105 related articles for article (PubMed ID: 14673863)
1. Theoretical studies on the mode of inhibition of ribonucleotide reductase by 2'-substituted substrate analogues.
Fernandes PA; Ramos MJ
Chemistry; 2003 Dec; 9(23):5916-25. PubMed ID: 14673863
[TBL] [Abstract][Full Text] [Related]
2. Theoretical studies on the mechanism of inhibition of Ribonucleotide Reductase by (E)-2'-Fluoromethylene-2'-deoxycitidine-5'-diphosphate.
Fernandes PA; Ramos MJ
J Am Chem Soc; 2003 May; 125(20):6311-22. PubMed ID: 12785865
[TBL] [Abstract][Full Text] [Related]
3. Enzyme ribonucleotide reductase: unraveling an enigmatic paradigm of enzyme inhibition by furanone derivatives.
Cerqueira NM; Fernandes PA; Ramos MJ
J Phys Chem B; 2006 Oct; 110(42):21272-81. PubMed ID: 17048956
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic and theoretical approaches for studying radical reactions in class I ribonucleotide reductase.
Bennati M; Lendzian F; Schmittel M; Zipse H
Biol Chem; 2005 Oct; 386(10):1007-22. PubMed ID: 16218873
[TBL] [Abstract][Full Text] [Related]
5. Theoretical study on the inhibition of ribonucleotide reductase by 2'-mercapto-2'-deoxyribonucleoside-5'-diphosphates.
Pereira S; Fernandes PA; Ramos MJ
J Am Chem Soc; 2005 Apr; 127(14):5174-9. PubMed ID: 15810852
[TBL] [Abstract][Full Text] [Related]
6. Theoretical study of ribonucleotide reductase mechanism-based inhibition by 2'-azido-2'-deoxyribonucleoside 5'-diphosphates.
Pereira S; Fernandes PA; Ramos MJ
J Comput Chem; 2004 Jan; 25(2):227-37. PubMed ID: 14648621
[TBL] [Abstract][Full Text] [Related]
7. Structure of the nitrogen-centered radical formed during inactivation of E. coli ribonucleotide reductase by 2'-azido-2'-deoxyuridine-5'-diphosphate: trapping of the 3'-ketonucleotide.
Fritscher J; Artin E; Wnuk S; Bar G; Robblee JH; Kacprzak S; Kaupp M; Griffin RG; Bennati M; Stubbe J
J Am Chem Soc; 2005 Jun; 127(21):7729-38. PubMed ID: 15913363
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of ribonucleotide reductase by (E)-2'-fluoromethylene-2'-deoxycytidine 5'-diphosphate: a paradigm for nucleotide mechanism-based inhibitors.
van der Donk WA; Yu G; Silva DJ; Stubbe J; McCarthy JR; Jarvi ET; Matthews DP; Resvick RJ; Wagner E
Biochemistry; 1996 Jun; 35(25):8381-91. PubMed ID: 8679596
[TBL] [Abstract][Full Text] [Related]
9. pH Rate profiles of FnY356-R2s (n = 2, 3, 4) in Escherichia coli ribonucleotide reductase: evidence that Y356 is a redox-active amino acid along the radical propagation pathway.
Seyedsayamdost MR; Yee CS; Reece SY; Nocera DG; Stubbe J
J Am Chem Soc; 2006 Feb; 128(5):1562-8. PubMed ID: 16448127
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleotide reductase: a mechanistic portrait of substrate analogues inhibitors.
Perez MA; Cerqueira NM; Fernandes PA; Ramos MJ
Curr Med Chem; 2010; 17(26):2854-72. PubMed ID: 20858168
[TBL] [Abstract][Full Text] [Related]
11. Detection of a new substrate-derived radical during inactivation of ribonucleotide reductase from Escherichia coli by gemcitabine 5'-diphosphate.
van der Donk WA; Yu G; Pérez L; Sanchez RJ; Stubbe J; Samano V; Robins MJ
Biochemistry; 1998 May; 37(18):6419-26. PubMed ID: 9572859
[TBL] [Abstract][Full Text] [Related]
12. A stable FeIII-FeIV replacement of tyrosyl radical in a class I ribonucleotide reductase.
Voevodskaya N; Lendzian F; Gräslund A
Biochem Biophys Res Commun; 2005 May; 330(4):1213-6. PubMed ID: 15823572
[TBL] [Abstract][Full Text] [Related]
13. Ribonucleotide reductases: radical chemistry and inhibition at the active site.
Robins MJ
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):519-34. PubMed ID: 14565227
[TBL] [Abstract][Full Text] [Related]
14. Density functional theory study of the manganese-containing ribonucleotide reductase from Chlamydia trachomatis: why manganese is needed in the active complex.
Roos K; Siegbahn PE
Biochemistry; 2009 Mar; 48(9):1878-87. PubMed ID: 19220003
[TBL] [Abstract][Full Text] [Related]
15. The radical site in chlamydial ribonucleotide reductase defines a new R2 subclass.
Högbom M; Stenmark P; Voevodskaya N; McClarty G; Gräslund A; Nordlund P
Science; 2004 Jul; 305(5681):245-8. PubMed ID: 15247479
[TBL] [Abstract][Full Text] [Related]
16. Crystals of the ribonucleotide reductase R2 protein from Chlamydia trachomatis obtained by heavy-atom co-crystallization.
Stenmark P; Högbom M; Roshick C; McClarty G; Nordlund P
Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):376-8. PubMed ID: 14747731
[TBL] [Abstract][Full Text] [Related]
17. Oligopeptide inhibition of class I ribonucleotide reductases.
Cooperman BS
Biopolymers; 2003; 71(2):117-31. PubMed ID: 12767114
[TBL] [Abstract][Full Text] [Related]
18. Ribonucleotide activation by enzyme ribonucleotide reductase: understanding the role of the enzyme.
Cerqueira NM; Fernandes PA; Eriksson LA; Ramos MJ
J Comput Chem; 2004 Dec; 25(16):2031-7. PubMed ID: 15481089
[TBL] [Abstract][Full Text] [Related]
19. Understanding ribonucleotide reductase inactivation by gemcitabine.
Cerqueira NM; Fernandes PA; Ramos MJ
Chemistry; 2007; 13(30):8507-15. PubMed ID: 17636467
[TBL] [Abstract][Full Text] [Related]
20. Circular dichroism and magnetic circular dichroism studies of the active site of p53R2 from human and mouse: iron binding and nature of the biferrous site relative to other ribonucleotide reductases.
Wei PP; Tomter AB; Røhr AK; Andersson KK; Solomon EI
Biochemistry; 2006 Nov; 45(47):14043-51. PubMed ID: 17115699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
